DE3370478D1 - Isoquinolinesulfonamide derivatives and process for the preparation thereof - Google Patents

Isoquinolinesulfonamide derivatives and process for the preparation thereof

Info

Publication number
DE3370478D1
DE3370478D1 DE8383111095T DE3370478T DE3370478D1 DE 3370478 D1 DE3370478 D1 DE 3370478D1 DE 8383111095 T DE8383111095 T DE 8383111095T DE 3370478 T DE3370478 T DE 3370478T DE 3370478 D1 DE3370478 D1 DE 3370478D1
Authority
DE
Germany
Prior art keywords
group
alkyl group
hydrogen atom
action
linked directly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8383111095T
Other languages
English (en)
Inventor
Hiroyoshi Hidaka
Takanori Sone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Asahi Chemical Industry Co Ltd
Original Assignee
Asahi Chemical Industry Co Ltd
Asahi Kasei Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Industry Co Ltd, Asahi Kasei Kogyo KK filed Critical Asahi Chemical Industry Co Ltd
Application granted granted Critical
Publication of DE3370478D1 publication Critical patent/DE3370478D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
DE8383111095T 1982-11-18 1983-11-07 Isoquinolinesulfonamide derivatives and process for the preparation thereof Expired DE3370478D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57201085A JPS5993054A (ja) 1982-11-18 1982-11-18 イソキノリンスルホン酸アミド誘導体

Publications (1)

Publication Number Publication Date
DE3370478D1 true DE3370478D1 (en) 1987-04-30

Family

ID=16435138

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383111095T Expired DE3370478D1 (en) 1982-11-18 1983-11-07 Isoquinolinesulfonamide derivatives and process for the preparation thereof

Country Status (5)

Country Link
US (2) US4634770A (de)
EP (1) EP0109023B1 (de)
JP (1) JPS5993054A (de)
AT (1) ATE26112T1 (de)
DE (1) DE3370478D1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678783B1 (en) * 1983-11-04 1995-04-04 Asahi Chemical Ind Substituted isoquinolinesulfonyl compounds
JPS61227581A (ja) * 1985-04-02 1986-10-09 Asahi Chem Ind Co Ltd 血管拡張剤
DE3438694A1 (de) * 1984-10-23 1986-04-24 Basf Ag, 6700 Ludwigshafen Neue amidoalkylmelamine und aminoalkylmelamine und verfahren zu ihrer herstellung
EP0187371B1 (de) * 1984-12-27 1991-06-19 Asahi Kasei Kogyo Kabushiki Kaisha Substituierte Isochinolinsulfonyl-Verbindungen
JPH0667926B2 (ja) * 1985-11-12 1994-08-31 旭化成工業株式会社 環状のイソキノリンスルホンアミド誘導体
US4857301A (en) * 1987-09-25 1989-08-15 Schering Corporation Sulfonamide compounds, compositions and method of use
JPH0215067A (ja) * 1988-07-04 1990-01-18 Hokuriku Seiyaku Co Ltd イソキノリンスルホンアミド誘導体
CA2005741C (en) * 1988-12-26 1998-06-02 Hiroyoshi Hidaka Quinoline sulfonoamino compounds having vessel smooth muscle relaxation activity
DE3942114C2 (de) * 1988-12-26 1997-09-04 Hiroyoshi Hidaka Verbindungen mit einer Wirkung für eine gleichmäßige Gefäßmuskelentspannung und pharmazeutische Zusammensetzung, die diese enthält
US5245034A (en) * 1988-12-26 1993-09-14 Kiroyoshi Hidaka Compound having vessel smooth muscle relaxation activity
US5340811A (en) * 1990-03-08 1994-08-23 Asahi Kasei Kogyo Kabushiki Kaisha Isoquinoline-or quinoline-sulfonamide derivative and a pharmaceutical composition comprising the same
US5326870A (en) * 1991-02-13 1994-07-05 Asahi Kasei Kogyo Kabushiki Kaisha Substituted sulfonamide derivative and a pharmaceutical composition comprising the same
JP2893029B2 (ja) * 1992-08-10 1999-05-17 旭化成工業株式会社 心臓保護剤
KR19990082174A (ko) * 1996-02-02 1999-11-25 니뽄 신야쿠 가부시키가이샤 이소퀴놀린 유도체 및 의약
CN100389828C (zh) 1996-08-12 2008-05-28 三菱制药株式会社 含Rho激酶抑制剂的药物制剂
DE19934272A1 (de) * 1999-07-21 2001-01-25 Bayer Ag Neue antivirale Mittel
EP1479386A1 (de) * 2003-04-30 2004-11-24 Switch Biotech Aktiengesellschaft Verwendung von Isochinolin-Derivaten zur Behandlung und Prophylaxe von Pigmentierungsstörungen
EP1878732B1 (de) * 2005-04-25 2009-02-25 D. Western Therapeutics Institute Hochselektiver rho-kinase-inhibitor
CA2638802A1 (en) * 2006-01-27 2007-10-25 Translational Genomics Research Institute Genes affecting human memory performance
CA2659289A1 (en) * 2006-08-10 2008-02-14 Translational Genomics Research Institute Compounds for improving learning and memory
CA2664335C (en) * 2006-09-20 2014-12-02 Boehringer Ingelheim International Gmbh Rho kinase inhibitors
US20090036465A1 (en) * 2006-10-18 2009-02-05 United Therapeutics Corporation Combination therapy for pulmonary arterial hypertension
US8455513B2 (en) 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
US8455514B2 (en) * 2008-01-17 2013-06-04 Aerie Pharmaceuticals, Inc. 6-and 7-amino isoquinoline compounds and methods for making and using the same
US8450344B2 (en) 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
EP3828172A1 (de) 2009-05-01 2021-06-02 Aerie Pharmaceuticals, Inc. Hemmer mit doppelmechanismus zur behandlung von erkrankungen
PL2444395T3 (pl) 2009-06-19 2016-06-30 D Western Therapeutics Inst Inc Podstawiona pochodna izochinoliny
US8258341B2 (en) * 2009-07-10 2012-09-04 E.I. Du Pont De Nemours And Company Polyfluorosulfonamido amine and intermediate
ES2852377T3 (es) 2013-03-15 2021-09-13 Aerie Pharmaceuticals Inc Sales dimesilato de 4-(3-amino-1-(isoquinolin-6-ilamino)-1-oxopropan-2-il)bencilo, sus combinaciones con prostaglandinas y el uso de las mismas en el tratamiento de trastornos oculares
US9643927B1 (en) 2015-11-17 2017-05-09 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
JP6832946B2 (ja) 2015-11-17 2021-02-24 アエリエ ファーマシューティカルズ インコーポレイテッド キナーゼ阻害剤およびその中間体の調製方法
MX2019002396A (es) 2016-08-31 2019-07-08 Aerie Pharmaceuticals Inc Composiciones oftalmicas.
CN110506037A (zh) 2017-03-31 2019-11-26 爱瑞制药公司 芳基环丙基-氨基-异喹啉酰胺化合物
US11427563B2 (en) 2018-09-14 2022-08-30 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4097591A (en) * 1974-11-08 1978-06-27 Mitsubishi Chemical Industries Limited N2 -arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4097472A (en) * 1974-11-08 1978-06-27 Mitsubishi Chemical Industries Limited N2 -arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof
IE48623B1 (en) * 1978-08-31 1985-03-20 Mitsubishi Chem Ind Alpha-(n-arylsulfonyl-l-argininamides,processes for their preparation and pharmaceutical compositions containing these substances
US4369320A (en) * 1980-11-03 1983-01-18 E. I. Du Pont De Nemours And Company N-[Heterocyclicaminocarbonyl]-8-quinolinesulfonamides
US4456757A (en) * 1981-03-20 1984-06-26 Asahi Kasei Kogyo Kabushiki Kaisha Isoquinolinesulfonyl derivatives and process for the preparation thereof

Also Published As

Publication number Publication date
US4634770A (en) 1987-01-06
EP0109023B1 (de) 1987-03-25
ATE26112T1 (de) 1987-04-15
US4709032A (en) 1987-11-24
JPH0428698B2 (de) 1992-05-15
JPS5993054A (ja) 1984-05-29
EP0109023A1 (de) 1984-05-23

Similar Documents

Publication Publication Date Title
DE3370478D1 (en) Isoquinolinesulfonamide derivatives and process for the preparation thereof
ES8506677A1 (es) Un procedimiento para la preparacion de nuevos derivados de 8-cloro71,5-benzotiazepina.
DE3271269D1 (en) Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same
ES8605506A1 (es) Procedimiento para preparar derivados de piperidina
DK44682A (da) Fremgangsmaade til fremstilling af substituerede imidazolderivater
ZA8742B (en) Derivatives of decahydroquinoline,their preparation process,the preparation intermediates,their use as medicaments and the compositions containing them
SE8406302L (sv) Nya aminoguanidinderivat och ett forfarande for deras framstellning
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
PT87277A (pt) Process for the preparation of new bicyclic compounds and pharmaceutical compositions comprising same
ES8601201A1 (es) Procedimiento para preparar derivados de imidazolina
ATE24503T1 (de) Phenylpiperazin-derivate und verfahren zu deren herstellung.
PH25314A (en) New naphthyl derivatives, pharmaceutical compositions containing these compounds , their method of use
SE8401398L (sv) 7-oxabicykloheptansubstituerade prostaglandinanaloger
ES454063A1 (es) Un procedimiento para la preparacion de nuevos derivados delalcohol bencilico.
DE69324854D1 (de) Pyridazinone-Derivate und Verfahren zur deren Herstellung
ATE41659T1 (de) Benzothiazepinderivate, verfahren zur herstellung und pharmazeutische zusammensetzungen.
ES8106517A1 (es) Procedimiento para la preparacion de nuevos derivados de 10-halogen-e-homo-eburnanos.
PL238869A1 (en) Process for preparing novel 1-furyl-3,4-dihydroisoquinolines
HUT41781A (en) Process for producing new 1-alkyl-ergoline-thio-urea derivatives
PT78618A (en) Process for preparing substituted isoquinoline derivatives and of pharmaceutical compositions containing the same
PT79821B (fr) Procede de preparation d'aminoethylimidazole comme de la composition pharmaceutique en contenant utilise comme medicament cytoprotecteur
IE790924L (en) 1,3-benzodioxin derivatives
ES8106714A1 (es) Procedimiento de preparar derivados 1,2,4-oxadiacinicos
ATE23155T1 (de) Aminozyklopentanol saeure und ester, ein verfahren zu ihrer herstellung und ihre pharmazeutische zusammensetzung.
SE8601798L (sv) Forfarande for framstellning av eburnamenin-derivat

Legal Events

Date Code Title Description
8364 No opposition during term of opposition